Table 3 Characteristics of MCA atherosclerotic plaques with and without enhancement

Age

57.1 ± 10.0

59.4 ± 8.5

52.6 ± 11.4

Sex (male)

17 (53.1%)

11 (52.4%)

6 (54.5%)

BMI

24.5 ± 3.5

24.6 ± 3.5

24.2 ± 4.0

Hypertension

20 (62.5%)

14 (66.7%)

6 (54.5%)

Diabetes

11 (34.4%)

7 (33.3%)

4 (36.4%)

Smoking

10 (31.3%)

7 (33.3%)

3 (27.3%)

Drinking

5 (15.6%)

4 (19.0%)

1 (9.1%)

Degree of stenosis

70–99%

20 (62.5%)

16 (76.2%)

4 (36.4%)

50–69%

9 (28.1%)

3 (14.3%)

6 (54.5%)

< 50%

3 (9.4%)

2 (9.5%)

1 (9.1%)

WBC (× 10⁹/L)

7.2 ± 1.6

7.4 ± 1.6

7.0 ± 1.8

LYM (× 10⁹/L)

2.0 ± 0.6

1.9 ± 0.6

2.2 ± 0.7

NEUT (× 10⁹/L)

4.4 ± 1.3

4.6 ± 1.3

4.1 ± 1.4

MONO (× 10⁹/L)

0.5 ± 0.2

0.6 ± 0.2

0.5 ± 0.3

Platelets (× 10⁹/L)

245.5 ± 46.8

248.5 ± 46.5

239.8 ± 50.8

GLU(mmol/L)

6.4 ± 2.9

6.4 ± 2.7

6.3 ± 3.5

Cholesterol (mmol/L)

4.9 ± 1.4

4.8 ± 1.7

5.2 ± 0.9

Triglyceride (mmol/L)

1.9 ± 0.9

1.8 ± 0.8

2.0 ± 1.1

HDL (mmol/L)

1.1 ± 0.3

1.0 ± 0.3

1.1 ± 0.3

LDL (mmol/L)

3.2 ± 1.1

3.1 ± 1.3

3.3 ± 0.7

Apolipoprotein E (mg/L)

36.6 ± 11.0

34.5 ± 10.7

40.6 ± 10.7

hsCRP (mmol/L)

1.7 (0.2–26.9),

1.4 (0.2–18.3),

2.1 (0.6–26.9),

NLR

2.4 ± 1.1

2.6 ± 1.1

2.0 ± 1.0

LMR

4.1 ± 1.5

3.5 ± 1.0

5.0 ± 1.9

LMR ≤ 4.0 (%)

17 (53.1%)

14 (66.7%)

3(27.3%)

PLR

133.4 ± 49.6

143.0 ± 52.2

115.1 ± 40.0

SII

603.1 ± 319.8

668.6 ± 335.1

478.2 ± 257.4

Plaque burden

0.8 ± 0.1

0.8 ± 0.1

0.7 ± 0.1

Plaque area (mm²)

13.2 ± 6.9

14.2 ± 6.8

11.3 ± 7.0

WSSmax (Pa)

258.1 ± 142.0

276.8 ± 141.7

222.5 ± 142.1

WSSR

85.0 ± 54.2

107.0 ± 49.3

43.1 ± 36.3

PR

0.7 ± 0.2

0.7 ± 0.2

0.7 ± 0.3

Hospitalization days

10.4 ± 5.4

11.9 ± 5.6

7.6 ± 3.9